Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuraxis (NRXS) Notes Payables (2022 - 2025)

Neuraxis' Notes Payables history spans 4 years, with the latest figure at $195658.0 for Q3 2025.

  • For Q3 2025, Notes Payables rose 32.48% year-over-year to $195658.0; the TTM value through Sep 2025 reached $195658.0, up 32.48%, while the annual FY2024 figure was $154152.0, 4.11% up from the prior year.
  • Notes Payables for Q3 2025 was $195658.0 at Neuraxis, up from $121433.0 in the prior quarter.
  • Across five years, Notes Payables topped out at $2.6 million in Q1 2023 and bottomed at $38797.0 in Q2 2024.
  • The 4-year median for Notes Payables is $174200.5 (2023), against an average of $539989.3.
  • The largest annual shift saw Notes Payables tumbled 96.81% in 2024 before it soared 213.0% in 2025.
  • A 4-year view of Notes Payables shows it stood at $228342.0 in 2022, then tumbled by 35.16% to $148062.0 in 2023, then rose by 4.11% to $154152.0 in 2024, then increased by 26.93% to $195658.0 in 2025.
  • Per Business Quant, the three most recent readings for NRXS's Notes Payables are $195658.0 (Q3 2025), $121433.0 (Q2 2025), and $84307.0 (Q1 2025).